Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) — Capital Reinvestment Ratio
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Capital Reinvestment Ratio of 0.18x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥1.84 Billion) in capital expenditures (CN¥330.65 Million). See Guangzhou Baiyunshan Pharmaceutical Hold (600332) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Capital Reinvestment Ratio (2000–2025)
This chart tracks Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Capital Reinvestment Ratio across 24 annual periods.
Annual Capital Reinvestment Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2025)
Year-by-year Capital Reinvestment Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd from 2000 to 2025. For live market cap and broader valuation context, see Guangzhou Baiyunshan Pharmaceutical Hold market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 4.76x | CN¥260.23 Million | CN¥1.24 Billion | ▲ +1353.9% |
| 2024 | 0.33x | CN¥3.44 Billion | CN¥1.13 Billion | ▼ -17.4% |
| 2023 | 0.40x | CN¥4.10 Billion | CN¥1.63 Billion | ▲ +100.7% |
| 2022 | 0.20x | CN¥7.00 Billion | CN¥1.38 Billion | ▼ -10.6% |
| 2021 | 0.22x | CN¥5.67 Billion | CN¥1.25 Billion | ▼ -85.2% |
| 2020 | 1.50x | CN¥585.19 Million | CN¥876.50 Million | ▲ +213.5% |
| 2019 | 0.48x | CN¥5.02 Billion | CN¥2.40 Billion | ▲ +420.8% |
| 2018 | 0.09x | CN¥5.22 Billion | CN¥478.62 Million | ▼ -14.5% |
| 2017 | 0.11x | CN¥1.83 Billion | CN¥196.77 Million | ▲ +15.0% |
| 2016 | 0.09x | CN¥2.44 Billion | CN¥228.03 Million | ▼ -64.9% |
| 2015 | 0.27x | CN¥1.94 Billion | CN¥515.34 Million | ▲ +32.2% |
| 2014 | 0.20x | CN¥1.76 Billion | CN¥353.65 Million | ▼ -23.3% |
| 2013 | 0.26x | CN¥1.34 Billion | CN¥350.35 Million | ▲ +151.9% |
| 2012 | 0.10x | CN¥506.53 Million | CN¥52.61 Million | ▼ -90.9% |
| 2010 | 1.14x | CN¥73.17 Million | CN¥83.20 Million | ▲ +470.6% |
| 2009 | 0.20x | CN¥439.39 Million | CN¥87.56 Million | ▼ -99.0% |
| 2008 | 20.80x | CN¥6.10 Million | CN¥126.98 Million | ▲ +6271.7% |
| 2007 | 0.33x | CN¥375.74 Million | CN¥122.69 Million | ▼ -86.0% |
| 2006 | 2.33x | CN¥38.88 Million | CN¥90.45 Million | ▲ +173.7% |
| 2005 | 0.85x | CN¥146.32 Million | CN¥124.36 Million | ▼ -44.8% |
| 2004 | 1.54x | CN¥200.54 Million | CN¥308.69 Million | ▲ +49.8% |
| 2002 | 1.03x | CN¥169.01 Million | CN¥173.70 Million | ▼ -10.2% |
| 2001 | 1.14x | CN¥140.15 Million | CN¥160.44 Million | ▲ +100.9% |
| 2000 | 0.57x | CN¥286.95 Million | CN¥163.53 Million | — |